• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路致病性大肠杆菌的生物膜形成在模拟膀胱环境的含氧条件下更为有利。

Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.

机构信息

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Department of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.

出版信息

Int J Mol Sci. 2017 Sep 30;18(10):2077. doi: 10.3390/ijms18102077.

DOI:10.3390/ijms18102077
PMID:28973965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5666759/
Abstract

One of the most common urologic problems afflicting millions of people worldwide is urinary tract infection (UTI). The severity of UTIs ranges from asymptomatic bacteriuria to acute cystitis, and in severe cases, pyelonephritis and urosepsis. The primary cause of UTIs is uropathogenic (UPEC), for which current antibiotic therapies often fail. UPEC forms multicellular communities known as biofilms on urinary catheters, as well as on and within bladder epithelial cells. Biofilm formation protects UPEC from environmental conditions, antimicrobial therapy, and the host immune system. Previous studies have investigated UPEC biofilm formation in aerobic conditions (21% oxygen); however, urine oxygen tension is reduced (4-6%), and urine contains molecules that can be used by UPEC as alternative terminal electron acceptors (ATEAs) for respiration. This study was designed to determine whether these different terminal electron acceptors utilized by influence biofilm formation. A panel of 50 urine-associated isolates was tested for the ability to form biofilm under anaerobic conditions and in the presence of ATEAs. Biofilm production was reduced under all tested sub-atmospheric levels of oxygen, with the notable exception of 4% oxygen, the reported concentration of oxygen within the bladder.

摘要

全世界数百万人都受到一种常见泌尿科问题的困扰,即尿路感染(UTI)。UTI 的严重程度从无症状菌尿到急性膀胱炎不等,严重情况下会发展为肾盂肾炎和脓毒症。UTI 的主要病因是尿路致病性大肠杆菌(UPEC),目前的抗生素疗法通常对此无效。UPEC 会在导尿管以及膀胱上皮细胞上形成称为生物膜的多细胞群落。生物膜的形成可保护 UPEC 免受环境条件、抗菌治疗和宿主免疫系统的影响。先前的研究已经在有氧条件(21%氧气)下研究了 UPEC 生物膜的形成;然而,尿液中的氧气张力会降低(4-6%),并且尿液中含有可被 UPEC 用作替代末端电子受体(ATEAs)进行呼吸的分子。本研究旨在确定这些不同的末端电子受体是否会影响生物膜的形成。测试了一组 50 种与尿液相关的 分离株在厌氧条件下和存在 ATEAs 时形成生物膜的能力。在所有测试的亚大气氧水平下,生物膜的产生均减少,只有 4%的氧气是个例外,这是膀胱内报告的氧气浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/8856727cd605/ijms-18-02077-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/e312fde957e7/ijms-18-02077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/65dc2841eb50/ijms-18-02077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/5481e6c51da0/ijms-18-02077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/a41c85a59df9/ijms-18-02077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/8856727cd605/ijms-18-02077-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/e312fde957e7/ijms-18-02077-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/65dc2841eb50/ijms-18-02077-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/5481e6c51da0/ijms-18-02077-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/a41c85a59df9/ijms-18-02077-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d1c/5666759/8856727cd605/ijms-18-02077-g005.jpg

相似文献

1
Biofilm Formation by Uropathogenic Escherichia coli Is Favored under Oxygen Conditions That Mimic the Bladder Environment.尿路致病性大肠杆菌的生物膜形成在模拟膀胱环境的含氧条件下更为有利。
Int J Mol Sci. 2017 Sep 30;18(10):2077. doi: 10.3390/ijms18102077.
2
The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.尿路致病性大肠杆菌中1型菌毛的表达、生物膜形成和致病作用需要泛醌I(VisC)需氧泛醌合酶。
J Bacteriol. 2016 Sep 9;198(19):2662-72. doi: 10.1128/JB.00030-16. Print 2016 Oct 1.
3
Inhibition and Inactivation of Uropathogenic Biofilms on Urinary Catheters by Sodium Selenite.亚硒酸钠对尿路致病性生物膜在导尿管上的抑制和失活作用。
Int J Mol Sci. 2018 Jun 7;19(6):1703. doi: 10.3390/ijms19061703.
4
Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.泌尿道感染发病过程中细胞内细菌群落中大肠杆菌的代谢需求
mBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16.
5
A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.系统评价和荟萃分析尿路感染分离的尿路致病性大肠埃希菌的抗生素耐药模式、生物膜形成与毒力因子之间的相关性。
Microb Pathog. 2020 Jul;144:104196. doi: 10.1016/j.micpath.2020.104196. Epub 2020 Apr 10.
6
Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.B2 型进化群的耐药性尿路致病性大肠埃希菌表现出显著的生物膜形成。
Libyan J Med. 2021 Dec;16(1):1845444. doi: 10.1080/19932820.2020.1845444.
7
Characterization and zoonotic potential of uropathogenic Escherichia coli isolated from dogs.从狗中分离的泌尿道致病性大肠杆菌的特性及人畜共患病潜力。
J Microbiol Biotechnol. 2013 Mar;23(3):422-9. doi: 10.4014/jmb.1209.09051.
8
Escherichia coli biofilm formation and recurrences of urinary tract infections in children.大肠埃希菌生物膜形成与儿童尿路感染复发。
Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):111-5. doi: 10.1007/s10096-013-1935-4. Epub 2013 Sep 2.
9
Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.木犀草素可降低尿路致病性大肠杆菌(UPEC)在膀胱上皮细胞中的黏附、侵袭及细胞毒性,并抑制UPEC生物膜形成。
Food Chem Toxicol. 2014 Oct;72:204-11. doi: 10.1016/j.fct.2014.07.019. Epub 2014 Jul 19.
10
Effect of different antibiotics on biofilm produced by uropathogenic Escherichia coli isolated from children with urinary tract infection.不同抗生素对从尿路感染患儿分离出的尿路致病性大肠杆菌产生的生物膜的影响。
Pathog Dis. 2017 Jun 1;75(4). doi: 10.1093/femspd/ftx053.

引用本文的文献

1
A rational approach to discovering new persister control agents.一种发现新型持留菌控制剂的合理方法。
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0181424. doi: 10.1128/aac.01814-24. Epub 2025 Jul 31.
2
Rapid assembly of biofilms from DNA released by SOS-inducing drugs in enteric bacteria.由SOS诱导药物释放的DNA在肠道细菌中快速组装生物膜。
Sci Rep. 2025 Apr 13;15(1):12711. doi: 10.1038/s41598-025-96943-2.
3
Are causing recurrent cystitis just ordinary uropathogenic (UPEC) strains?导致复发性膀胱炎的仅仅是普通的尿路致病性大肠杆菌(UPEC)菌株吗?

本文引用的文献

1
Trimethylamine N-Oxide: The Good, the Bad and the Unknown.氧化三甲胺:有益、有害与未知之处
Toxins (Basel). 2016 Nov 8;8(11):326. doi: 10.3390/toxins8110326.
2
Urinary Tract Infection: Pathogenesis and Outlook.尿路感染:发病机制与展望
Trends Mol Med. 2016 Nov;22(11):946-957. doi: 10.1016/j.molmed.2016.09.003. Epub 2016 Sep 28.
3
Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.携带mcr-1和blaNDM-5基因的耐黏菌素和耐碳青霉烯类大肠杆菌,导致一名美国患者发生复杂性尿路感染
Virulence. 2025 Dec;16(1):2444689. doi: 10.1080/21505594.2024.2444689. Epub 2024 Dec 26.
4
Differential Expression of , , , and Genes in Biofilms- and Suspension-Grown Bacteria From Samples of Different Uropathogenic Strains of .来自不同尿道致病性大肠杆菌菌株样本的生物膜生长细菌和悬浮生长细菌中、、、和基因的差异表达
Int J Microbiol. 2024 Dec 12;2024:5235071. doi: 10.1155/ijm/5235071. eCollection 2024.
5
Antibacterial and Anti-biofilm Effects of Thymoquinone Against Carbapenem-Resistant Uropathogenic .百里醌对耐碳青霉烯类尿路致病性细菌的抗菌及抗生物膜作用
Indian J Microbiol. 2024 Dec;64(4):1747-1756. doi: 10.1007/s12088-024-01231-8. Epub 2024 Mar 5.
6
Transposon mutagenesis screen in identifies genetic determinants required for growth in human urine and serum.转座子突变体筛选鉴定了在人尿液和血清中生长所必需的遗传决定因素。
Elife. 2024 Aug 27;12:RP88971. doi: 10.7554/eLife.88971.
7
Intra-strain colony biofilm heterogeneity in uropathogenic and the effect of the NlpI lipoprotein.尿路致病性菌株内菌落生物膜的异质性及NlpI脂蛋白的作用
Biofilm. 2024 Jul 17;8:100214. doi: 10.1016/j.bioflm.2024.100214. eCollection 2024 Dec.
8
High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli.高通量组合测定法用于研究尿路致病性大肠埃希菌生物膜的形成。
Arch Microbiol. 2024 Jul 5;206(8):344. doi: 10.1007/s00203-024-04029-w.
9
Current understandings of colibactin regulation.当前对大肠杆菌素调控的理解。
Microbiology (Reading). 2024 Feb;170(2). doi: 10.1099/mic.0.001427.
10
Are causing recurrent cystitis just ordinary Uropathogenic (UPEC) strains?引发复发性膀胱炎的仅仅是普通的尿路致病性大肠杆菌(UPEC)菌株吗?
bioRxiv. 2023 Nov 9:2023.11.08.566351. doi: 10.1101/2023.11.08.566351.
mBio. 2016 Aug 30;7(4):e01191-16. doi: 10.1128/mBio.01191-16.
4
The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.尿路致病性大肠杆菌中1型菌毛的表达、生物膜形成和致病作用需要泛醌I(VisC)需氧泛醌合酶。
J Bacteriol. 2016 Sep 9;198(19):2662-72. doi: 10.1128/JB.00030-16. Print 2016 Oct 1.
5
Proteus mirabilis fimbriae- and urease-dependent clusters assemble in an extracellular niche to initiate bladder stone formation.奇异变形杆菌的菌毛和尿素酶依赖性簇在细胞外微环境中组装,以启动膀胱结石形成。
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4494-9. doi: 10.1073/pnas.1601720113. Epub 2016 Apr 4.
6
The emerging threat of multidrug-resistant Gram-negative bacteria in urology.泌尿外科学中出现的多重耐药革兰氏阴性菌的新威胁。
Nat Rev Urol. 2015 Oct;12(10):570-84. doi: 10.1038/nrurol.2015.199. Epub 2015 Sep 1.
7
Metabolism and Fitness of Urinary Tract Pathogens.尿路病原体的代谢与适应性。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0016-2015.
8
Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli.人尿可降低致病性大肠杆菌1型菌毛的功能和表达。
mBio. 2015 Jun 30;6(4):e00820. doi: 10.1128/mBio.00820-15.
9
Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili.尿路致病性大肠杆菌生物膜中的黏附性纤维分层揭示了氧对1型菌毛的介导控制。
PLoS Pathog. 2015 Mar 4;11(3):e1004697. doi: 10.1371/journal.ppat.1004697. eCollection 2015 Mar.
10
Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli.杀芽胞菌素ec240破坏尿路致病性大肠杆菌中的毒力回路。
mBio. 2014 Oct 28;5(6):e02038. doi: 10.1128/mBio.02038-14.